Effect of Non-Invasive Ventilation in Cystic Fibrosis Patient With Chronic Respiratory Failure.
NCT00208078 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 36
Last updated 2013-02-13
Summary
There is no randomised controlled trials to determine the clinical effects of long term Non-Invasive Ventilation in Cystic Fibrosis patients.
Conditions
- Cystic Fibrosis
- Chronic Respiratory Failure
Interventions
- DEVICE
-
pressure support ventilator
Non invasive ventilation 4h/d 5 days a week
Sponsors & Collaborators
-
Cochin Hospital
lead AMBIG
Principal Investigators
-
Pierre-Régis Burgel · Department of pulmonary disease of Cochin Hospital (AP-HP)
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-05-31
- Primary Completion
- 2010-05-31
- Completion
- 2011-05-31
Countries
- France
Study Locations
More Related Trials
-
Sleep in Patients With Cystic Fibrosis
NCT00804661 ·Status: COMPLETED
-
Non-invasive Ventilation and Oxygen Therapy in Cystic Fibrosis Patients With Nocturnal Oxygen Desaturation
NCT00157183 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Timing of Hypertonic Saline Inhalation Relative to Airways Clearance in Cystic Fibrosis
NCT01753869 ·Status: TERMINATED ·Phase: NA
-
Pressure Support Ventilation During CF Exacerbations
NCT00008775 ·Status: SUSPENDED ·Phase: NA
-
Short-term Effects of Physiotherapy on LCI
NCT03760120 ·Status: COMPLETED ·Phase: NA
-
Comparison of Airway Clearance Efficacy of Two High Frequency Chest Wall Oscillation (HFCWO) Devices in Cystic Fibrosis
NCT00308958 ·Status: COMPLETED ·Phase: NA
-
Analysis of Remote Monitoring/Virtual Clinic Data in Adult Patients With Cystic Fibrosis (Project Breathe)
NCT06222905 ·Status: ACTIVE_NOT_RECRUITING
-
Prevalence of Exercise-induced Ventilatory Limitation and Associated Factors in Patients With Cystic Fibrosis Receiving Elexacaftor-Tezacaftor-Ivacaftor
NCT07314229 ·Status: RECRUITING ·Phase: NA
-
Long-term Study, Comparing Vest Therapy to Positive Expiratory Pressure (PEP) Therapy in the Treatment of Cystic Fibrosis
NCT00817180 ·Status: COMPLETED ·Phase: PHASE2
-
Researching the Effects of Airway Clearance Therapies in Cystic Fibrosis
NCT03078127 ·Status: COMPLETED ·Phase: NA
-
Intrapulmonary Percussive Ventilation for Sputum Induction in Adults With Cystic Fibrosis
NCT06311292 ·Status: COMPLETED ·Phase: NA
-
Web-based Delivery of Effective Treatment for Growth in Cystic Fibrosis
NCT01686672 ·Status: COMPLETED ·Phase: NA
-
Breath Condensate Study in Patients With Cystic Fibrosis.
NCT02056132 ·Status: COMPLETED
-
PEP and OPEP Devices in Cystic Fibrosis
NCT05801952 ·Status: UNKNOWN ·Phase: NA
-
Airway Secretion Clearance in Cystic Fibrosis
NCT00839644 ·Status: TERMINATED ·Phase: NA
-
Retrospective Observational Study to Compare Cystic Fibrosis Patients in Two Decades Before and After 2000
NCT01651455 ·Status: COMPLETED
-
Health Outcomes of Parents With Cystic Fibrosis-Aim 2
NCT06296394 ·Status: RECRUITING
-
Should Any One Airway Clearance Technique be Recommended for People With Cystic Fibrosis?
NCT00890370 ·Status: COMPLETED ·Phase: PHASE4
-
Home Monitoring to Predict Exacerbation in Cystic Fibrosis
NCT02416375 ·Status: COMPLETED
-
Air Pollution and Children With Cystic Fibrosis
NCT03853629 ·Status: COMPLETED
-
Respiratory Function at Preschool Age of Children Detected of Cystic Fibrosis in Neonatal Period
NCT02358798 ·Status: COMPLETED ·Phase: NA
-
Prognostic Value of Functional Exercise Test (EFX) in Cystic Fibrosis
NCT02994017 ·Status: COMPLETED ·Phase: NA
-
Non-respiratory Comorbidities Observed in Pulmonary French Transplant Patients With Cystic Fibrosis
NCT03357913 ·Status: COMPLETED
-
Positive Expiratory Pressure During Inhalation of Hypertonic Saline in Patients With Cystic Fibrosis
NCT02303808 ·Status: COMPLETED ·Phase: NA
-
Airway Clearance for Pediatric and Adult Cystic Fibrosis Patients Using a Portable Intra-Pulmonary Percussion Device
NCT04743206 ·Status: TERMINATED ·Phase: NA